Wells Fargo & Company Rigel Pharmaceuticals Inc Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.12 - $1.57 $7,856 - $11,013	7,015 Added 15.29%	52,902 $78,000
Q4 2023 Feb 09, 2024	BUY	$0.72 - $1.56 $6,110 - $13,239	8,487 Added 22.69%	45,887 $66,000
Q3 2023 Nov 13, 2023	SELL	$1.07 - $1.39 $39,063 - $50,746	-36,508 Reduced 49.4%	37,400 $40,000
Q2 2023 Aug 15, 2023	BUY	$1.12 - $1.82 $43,433 - $70,579	38,780 Added 110.4%	73,908 $95,000
Q1 2023 May 12, 2023	BUY	$1.25 - $2.0 $43,322 - $69,316	34,658 Added 7374.04%	35,128 $46,000
Q4 2022 Feb 13, 2023	SELL	$0.67 - $11.9 $2,115 - $37,568	-3,157 Reduced 87.04%	470 $0
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $14,166 - $157,123	-12,879 Reduced 78.03%	3,627 $5,000
Q2 2022 Aug 12, 2022	SELL	$0.67 - $3.19 $127,596 - $607,509	-190,442 Reduced 92.02%	16,506 $19,000
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $169,257 - $263,034	-76,242 Reduced 26.92%	206,948 $618,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $170,401 - $257,768	72,204 Added 34.22%	283,190 $750,000
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $3.91 Million - $5.03 Million	-1,118,138 Reduced 84.13%	210,986 $767,000
Q2 2021 Aug 16, 2021	BUY	$3.09 - $4.54 $1.9 Million - $2.8 Million	615,713 Added 86.31%	1,329,124 $5.77 Million
Q1 2021 May 13, 2021	BUY	$3.35 - $4.93 $1 Million - $1.48 Million	299,883 Added 72.52%	713,411 $2.44 Million
Q4 2020 Feb 09, 2021	SELL	$2.35 - $3.74 $327,540 - $521,277	-139,379 Reduced 25.21%	413,528 $1.45 Million
Q3 2020 Nov 05, 2020	SELL	$1.78 - $4.13 $1.08 Million - $2.51 Million	-608,496 Reduced 52.39%	552,907 $1.33 Million
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.05 $736,211 - $1.07 Million	522,136 Added 81.68%	1,161,403 $2.13 Million
Q1 2020 May 14, 2020	BUY	$1.27 - $3.0 $811,869 - $1.92 Million	639,267 New	639,267 $997,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

355K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.3B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account